Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 6,401–6,420 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Hydroxocobalamin Injection, HYDROXOCOBALAMIN 5MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0339-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin (hCG) Injection, HCG [10ML] 1000 IU/ML INJECTABLE, For IM, SC Use, Refrigerate,10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0533-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Glycine Injection,GLYCINE USP 50MG/ML INJECTABLE, For IV, IM Use,30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0344-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Glycerin (PF) Injection,GLYCERIN 99% INJECTABLE, For IV Use,10 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0464-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Glutathione Injection,GLUTATHIONE 200MG/ML INJECTABLE For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1231-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Dexpanthenol Injection, DEXPANTHENOL 250 MG/ML INJECTABLE, For IV, IM Use, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0214-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone (LA) Injectable Suspension, DEXAMETHASONE LA [10ML] 16MG INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0630-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Deoxycholic Acid Sodium Injection,DEOXYCHOLIC ACID SODIUM 1.67% INJECTABLE, For SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0462-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Cyanocobalamin/Folinic Acid Injection, CYANOCOBALAMIN : FOLINIC ACID 2000 MCG/ML: 500MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0333-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Cyanocobalamin Injection, CYANOCOBALAMIN 2000 MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0330-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Coenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0411-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Chloride Injection, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0225-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Biotin (Vitamin H) Injectable Suspension, BIOTIN 10 MG/ML INJ SUSP, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0220-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [5ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well. 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [10ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [2ML] 6MG/ML INJ SUSP, For IM, IA, IT Use, Shake Well. Preservative Free. Discard Unused Portion, 2 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0620-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX 110 INJECTABLE, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0212-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

AscorbiX (Buffered C) Injection, Ascorbix (30ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 40MCG/30MG/2MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0546-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.